Author:
Hasril M.,Luthfy M.,Riana A.,Ittaqa A. N.,Pawiro S. A.,Hardiansyah D.
Reference17 articles.
1. J. C. Reubi, J. C. Schaer, R. Markwalder, B. Waser, U. Horisberger, and J. Laissue, “Distribution of somatostatin receptors in normal and neoplastic human tissues: Recent advances and potential relevance,” 1997.
2. I. M. Modlin, I. Latich, M. Kidd, M. Zikusoka, and G. Eick, “Therapeutic Options for Gastrointestinal Carcinoids,” Clinical Gastroenterology and Hepatology. 2006.
3. J. C. Yao et al., “One hundred years after ‘carcinoid’: Epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States,” J. Clin. Oncol., 2008.
4. Peptide receptor radionuclide therapy using radiolabeled somatostatin analogs: focus on future developments
5. Peptide Receptor Radionuclide Therapy: An Overview